Annual Current Liabilities
$5.20 M
-$2.48 M-32.34%
31 December 2023
Summary:
Oncternal Therapeutics annual total current liabilities is currently $5.20 million, with the most recent change of -$2.48 million (-32.34%) on 31 December 2023. During the last 3 years, it has fallen by -$660.00 thousand (-11.27%). ONCT annual current liabilities is now -84.15% below its all-time high of $32.79 million, reached on 31 December 2014.ONCT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$6.45 M
-$1.60 M-19.89%
30 September 2024
Summary:
Oncternal Therapeutics quarterly total current liabilities is currently $6.45 million, with the most recent change of -$1.60 million (-19.89%) on 30 September 2024. Over the past year, it has increased by +$1.30 million (+25.25%). ONCT quarterly current liabilities is now -91.18% below its all-time high of $73.17 million, reached on 30 June 2015.ONCT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.3% | +25.3% |
| 3 y3 years | -11.3% | +10.9% |
| 5 y5 years | -0.2% | -4.7% |
ONCT Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.3% | at low | -19.9% | +33.6% |
| 5 y | 5 years | -32.3% | at low | -28.3% | +33.6% |
| alltime | all time | -84.2% | +296.2% | -91.2% | +254.8% |
Oncternal Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.45 M(-19.9%) |
| June 2024 | - | $8.05 M(+31.7%) |
| Mar 2024 | - | $6.12 M(+17.7%) |
| Dec 2023 | $5.20 M(-32.3%) | $5.20 M(+0.9%) |
| Sept 2023 | - | $5.15 M(+6.6%) |
| June 2023 | - | $4.83 M(-12.0%) |
| Mar 2023 | - | $5.49 M(-28.6%) |
| Dec 2022 | $7.68 M(+40.6%) | $7.68 M(+0.7%) |
| Sept 2022 | - | $7.63 M(+1.5%) |
| June 2022 | - | $7.51 M(+41.9%) |
| Mar 2022 | - | $5.29 M(-3.1%) |
| Dec 2021 | $5.46 M(-6.7%) | $5.46 M(-6.1%) |
| Sept 2021 | - | $5.82 M(-1.4%) |
| June 2021 | - | $5.90 M(+3.1%) |
| Mar 2021 | - | $5.72 M(-2.3%) |
| Dec 2020 | $5.86 M(-20.2%) | $5.86 M(-22.4%) |
| Sept 2020 | - | $7.55 M(-16.1%) |
| June 2020 | - | $9.00 M(+23.0%) |
| Mar 2020 | - | $7.32 M(-0.3%) |
| Dec 2019 | $7.34 M(+40.9%) | $7.34 M(+8.4%) |
| Sept 2019 | - | $6.77 M(-13.7%) |
| June 2019 | - | $7.84 M(+331.1%) |
| Mar 2019 | - | $1.82 M(-65.1%) |
| Dec 2018 | $5.21 M(-34.7%) | $5.21 M(-44.0%) |
| Sept 2018 | - | $9.30 M(+18.1%) |
| June 2018 | - | $7.88 M(-18.0%) |
| Mar 2018 | - | $9.61 M(+20.5%) |
| Dec 2017 | $7.97 M(+73.0%) | $7.97 M(-14.1%) |
| Sept 2017 | - | $9.28 M(+79.0%) |
| June 2017 | - | $5.18 M(+9.0%) |
| Mar 2017 | - | $4.76 M(+3.2%) |
| Dec 2016 | $4.61 M(-84.7%) | $4.61 M(+37.1%) |
| Sept 2016 | - | $3.36 M(-4.7%) |
| June 2016 | - | $3.53 M(+16.9%) |
| Mar 2016 | - | $3.02 M(-90.0%) |
| Dec 2015 | $30.17 M(-8.0%) | $30.17 M(-9.8%) |
| Sept 2015 | - | $33.47 M(-54.3%) |
| June 2015 | - | $73.17 M(+145.0%) |
| Mar 2015 | - | $29.87 M(-8.9%) |
| Dec 2014 | $32.79 M | $32.79 M(+1314.7%) |
| Sept 2014 | - | $2.32 M(-37.4%) |
| June 2014 | - | $3.70 M(-17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $4.51 M(-1.2%) |
| Dec 2013 | $4.57 M(-51.9%) | $4.57 M(-11.6%) |
| Sept 2013 | - | $5.17 M(-37.8%) |
| June 2013 | - | $8.30 M(+1.8%) |
| Mar 2013 | - | $8.15 M(-14.2%) |
| Dec 2012 | $9.49 M(+62.8%) | $9.49 M(-17.3%) |
| Sept 2012 | - | $11.48 M(+59.5%) |
| June 2012 | - | $7.19 M(+28.3%) |
| Mar 2012 | - | $5.61 M(-3.9%) |
| Dec 2011 | $5.83 M(+10.0%) | $5.83 M(+12.3%) |
| Sept 2011 | - | $5.20 M(+6.0%) |
| June 2011 | - | $4.90 M(+51.6%) |
| Mar 2011 | - | $3.23 M(-39.0%) |
| Dec 2010 | $5.30 M(-66.7%) | $5.30 M(-3.4%) |
| Sept 2010 | - | $5.49 M(-13.4%) |
| June 2010 | - | $6.34 M(-33.7%) |
| Mar 2010 | - | $9.57 M(-40.0%) |
| Dec 2009 | $15.95 M(-24.0%) | $15.95 M(-13.4%) |
| Sept 2009 | - | $18.43 M(+0.4%) |
| June 2009 | - | $18.36 M(-1.2%) |
| Mar 2009 | - | $18.59 M(-11.4%) |
| Dec 2008 | $20.98 M(+8.5%) | $20.98 M(+15.3%) |
| Sept 2008 | - | $18.20 M(-1.6%) |
| June 2008 | - | $18.50 M(-13.0%) |
| Mar 2008 | - | $21.26 M(+10.0%) |
| Dec 2007 | $19.33 M(+87.0%) | $19.33 M(+70.2%) |
| Sept 2007 | - | $11.36 M(-10.4%) |
| June 2007 | - | $12.68 M(+8.4%) |
| Mar 2007 | - | $11.69 M(+13.1%) |
| Dec 2006 | $10.34 M(+73.0%) | $10.34 M(-17.4%) |
| Sept 2006 | - | $12.52 M(+82.8%) |
| June 2006 | - | $6.85 M(-11.0%) |
| Mar 2006 | - | $7.70 M(+28.8%) |
| Dec 2005 | $5.97 M(+23.1%) | $5.97 M(-32.7%) |
| Sept 2005 | - | $8.88 M(+0.8%) |
| June 2005 | - | $8.81 M(+33.7%) |
| Mar 2005 | - | $6.59 M(+35.7%) |
| Dec 2004 | $4.85 M(+115.8%) | $4.85 M(+22.9%) |
| Sept 2004 | - | $3.95 M(-13.4%) |
| June 2004 | - | $4.56 M(+9.4%) |
| Mar 2004 | - | $4.17 M(+85.4%) |
| Dec 2003 | $2.25 M(+71.4%) | $2.25 M |
| Dec 2002 | $1.31 M | - |
FAQ
- What is Oncternal Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual current liabilities year-on-year change?
- What is Oncternal Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly current liabilities year-on-year change?
What is Oncternal Therapeutics annual total current liabilities?
The current annual current liabilities of ONCT is $5.20 M
What is the all time high annual current liabilities for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual total current liabilities is $32.79 M
What is Oncternal Therapeutics annual current liabilities year-on-year change?
Over the past year, ONCT annual total current liabilities has changed by -$2.48 M (-32.34%)
What is Oncternal Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ONCT is $6.45 M
What is the all time high quarterly current liabilities for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly total current liabilities is $73.17 M
What is Oncternal Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ONCT quarterly total current liabilities has changed by +$1.30 M (+25.25%)